UBS lowered its price target for McCormick from $52 to $48 following the company's Q3 fiscal 2026 results. Although McCormick beat expectations and confirmed its full-year outlook, its net income fell sharply to $97.6 million from $225.5 million year-over-year. Sales increased during the quarter, but the profit decline suggests rising costs or other operational challenges. McCormick's stock is trading near its 52-week low, reflecting cautious market sentiment despite sales growth.
McCormick (MKC) is trading close to its 52-week low of $44.14 on Pluang, currently priced at $44.65 as of Oct 03, 2026 00:03 WIB, showing a modest 1.16% gain in the last day. This price is significantly below its 52-week high of $71.65, indicating a wide range of volatility over the year. The stock's dividend yield stands at 4.14%, and investor activity on Pluang leans towards buying with 67% of orders being buys, despite the cautious sentiment reflected in its price position.
McCormick & Company reported fiscal Q3 results with adjusted EPS of $0.86, surpassing estimates of $0.76, and revenue of $2.02 billion, up 17.4% from last year. Growth was driven by the McCormick de Mexico acquisition, pricing actions, and favorable ...
McCormick & Company reported better-than-expected third-quarter adjusted earnings of $0.86 per share and net sales of $2.02 billion, driven by wider margins and the acquisition of McCormick de Mexico. Organic sales grew 1.9%, though volume slightly d...
McCormick & Company posted a 17.4% increase in net sales for Q3 2026, driven by acquisitions and organic growth, with gross profit margins expanding by 190 basis points. Adjusted operating income rose 22% despite a drop in reported operating income d...
